Volitionrx Limited (VNRX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts VNRX Hot Sheet
Join SI Premium – FREE
Volitionrx Limited (NYSE: VNRX) reported Q2 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
- Sharon AI surges premarket; New Oriental gains, Medline slips
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
